The safety and wellbeing of all clinical trial participants is of utmost importance for us. The pandemic character of the COVID-19 spread has substantial impact on clinical trials. We need to ensure the wellbeing and rights of our clinical trial participants, the safety of our employees and avoid non-compliance in our trials. As a result of the COVID-19 crisis, we have therefore decided...   

Clinical investigators and health authorities worldwide, where required, are currently being informed about this development. The situation will be constantly monitored and assessed.